Interleukin-18 enhances vascular calcification and osteogenic differentiation of vascular smooth muscle cells through TRPM7 activation

K Zhang, Y Zhang, W Feng, R Chen… - … , and vascular biology, 2017 - Am Heart Assoc
K Zhang, Y Zhang, W Feng, R Chen, J Chen, RM Touyz, J Wang, H Huang
Arteriosclerosis, thrombosis, and vascular biology, 2017Am Heart Assoc
Objective—Vascular calcification (VC) is an important predictor of cardiovascular morbidity
and mortality. Osteogenic differentiation of vascular smooth muscle cells (VSMCs) is a key
mechanism of VC. Recent studies show that IL-18 (interleukin-18) favors VC while TRPM7
(transient receptor potential melastatin 7) channel upregulation inhibits VC. However, the
relationship between IL-18 and TRPM7 is unclear. We questioned whether IL-18 enhances
VC and osteogenic differentiation of VSMCs through TRPM7 channel activation. Approach …
Objective
Vascular calcification (VC) is an important predictor of cardiovascular morbidity and mortality. Osteogenic differentiation of vascular smooth muscle cells (VSMCs) is a key mechanism of VC. Recent studies show that IL-18 (interleukin-18) favors VC while TRPM7 (transient receptor potential melastatin 7) channel upregulation inhibits VC. However, the relationship between IL-18 and TRPM7 is unclear. We questioned whether IL-18 enhances VC and osteogenic differentiation of VSMCs through TRPM7 channel activation.
Approach and Results
Coronary artery calcification and serum IL-18 were measured in patients by computed tomographic scanning and enzyme-linked immunosorbent assay, respectively. Primary rat VSMCs calcification were induced by high inorganic phosphate and exposed to IL-18. VSMCs were also treated with TRPM7 antagonist 2-aminoethoxy-diphenylborate or TRPM7 small interfering RNA to block TRPM7 channel activity and expression. TRPM7 currents were recorded by patch-clamp. Human studies showed that serum IL-18 levels were positively associated with coronary artery calcium scores (r=0.91; P<0.001). In VSMCs, IL-18 significantly decreased expression of contractile markers α-smooth muscle actin, smooth muscle 22 α, and increased calcium deposition, alkaline phosphatase activity, and expression of osteogenic differentiation markers bone morphogenetic protein-2, Runx2 (runt-related transcription factor 2), and osteocalcin (P<0.05). IL-18 increased TRPM7 expression through ERK1/2 (extracellular signal-regulated kinase 1/2) signaling activation, and TRPM7 currents were augmented by IL-18 treatment. Inhibition of TRPM7 channel by 2-aminoethoxy-diphenylborate or TRPM7 small interfering RNA prevented IL-18–enhanced osteogenic differentiation and VSMCs calcification.
Conclusions
These findings suggest that coronary artery calcification is associated with increased IL-18 levels. IL-18 enhances VSMCs osteogenic differentiation and subsequent VC induced by β-glycerophosphate via TRPM7 channel activation. Accordingly, IL-18 may contribute to VC in proinflammatory conditions.
Am Heart Assoc